Eflornithine
Eflornithine

49.3
A generic alternative indicated for Women's Health and Skin Care. This formulation targets enzyme activity in hair follicles, supporting the inhibition of unwanted facial hair growth.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Eflornithine Hydrochloride
Reference Brand
Vaniqa
Product Origin
Generic Product
Reference Manufacturer
Almirall
Product Form
Cream
Regulatory Classification
Rx
Primary Category
Skin Care
Product Category
Enzyme Inhibitor
Pharmacological Class
Ornithine Decarboxylase Inhibitor
Manufacturer Description
Intended to alleviate unwanted facial hair growth in women by addressing hair follicle activity to support improved skin appearance and mitigate regrowth rates.
Mechanism of Action
This cream blocks a specific enzyme in the hair follicle that is essential for hair growth. By slowing this process, the medication reduces the speed and amount of hair that grows back.
Route of Administration
Topical
Onset Time
4–8 weeks
Duration
Temporary (must continue use)
Contraindications
Hypersensitivity to eflornithine, Children under 12 years (topical)
Severe Adverse Events
Severe skin irritation, Allergic contact dermatitis, Angioedema (rare)
Common Side Effects
Skin stinging, Burning sensation
Uncommon Side Effects
Redness, Skin rash, Acne flare-up, Itching
Pregnancy Safety Warnings
Use only if benefit outweighs risk; safety data limited.
Age Restrictions
Not for use in children under 12.
Storage Guidelines
Store at room temperature; do not freeze.
Related Products
Laser therapy, Spironolactone
Information for Eflornithine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories